Zoetis receives european commission marketing authorization for solensia® (frunevetmab), a new therapy for feline osteoarthritis pain

Zaventem, belgium--(business wire)---- $zts #animalhealth--zoetis receives european commission marketing authorization for solensia® (frunevetmab), a new therapy for feline osteoarthritis pain.

ZTS Ratings Summary

ZTS Quant Ranking